Management of the Research Program Sample Clauses
Management of the Research Program. (a) The Research Collaboration will be managed by a Joint Research Committee composed of 4 members: 2 members to be designated by each party. The initial composition of the Joint Research Committee is set forth in Exhibit C. Each party will be entitled to designate from time-to-time a successor to the member previously designated by it unless the other party has a reasonable objection to such successor.
(b) The Joint Research Committee will hold meetings as necessary but at least twice per year, at times and locations to be mutually agreed upon. The minutes of the meetings will be recorded and marked "confidential" and will be subject to the secrecy obligations and restrictions on use contained in Paragraphs 12.2 and 12.3. * CONFIDENTIAL TREATMENT REQUESTED
(c) The Joint Research Committee will review and evaluate the work on the Research Collaboration. Its functions will be to decide:
(i) on Targets to be included within the Research Collaboration;
(ii) on Research Target Profiles for any Target (including any subsequent modifications of such Research Target Profile);
(iii) on therapeutic indications to be pursued for Compounds inhibiting a Target;
(iv) the territorial patenting strategy for Compounds and the "freedom to operate" position by patent due diligence on new Targets or Compounds;
(v) assignment of financial resources and personnel to specific Targets; and/or emphasis among Targets;
(vi) approval of Target-specific Research Plans;
(vii) determination of whether a Compound fulfills the Research Target Profile;
(viii) approval of Excess Research Costs;
(ix) when necessary, on taking appropriate action to adopt alternative approaches or to make recommendations on redirecting or restructuring the Research Plan set out in Exhibit B; and
(x) determine the detailed manufacturing specifications for research Compounds
(d) The Joint Research Committee will act by unanimous decision. Disputes will be resolved pursuant to Paragraph 13.11 hereof.
Management of the Research Program. The Parties will establish and maintain a joint steering committee to oversee the conduct of the Research Program and, following completion of the Research Program, to serve as an information-sharing forum with respect to development, registration, Manufacture and commercialization of Lead Compounds and Products by or on behalf of AstraZeneca, its Affiliates and Sublicensees pursuant to this Agreement (the “JSC”). The JSC will be established, operated and governed in accordance with the policies and procedures set forth in APPENDIX 2 attached hereto (the “Research Program Management Charter”). The Research Program Management Charter may only be amended by mutual written agreement of the Parties. As needed, the JSC will establish subcommittees and working groups that will report to the JSC to further the objectives of the Research Program and, following completion of the Research Program, to further the objectives of the information-sharing objectives of the JSC.
Management of the Research Program. (a) The Research Collaboration will be managed by a Joint Research Committee composed of 4 members: 2 members to be designated by each party. The initial composition of the Joint Research Committee is set forth in Exhibit C. Each party will be entitled to designate from time-to-time a successor to the member previously designated by it unless the other party has a reasonable objection to such successor.
(b) The Joint Research Committee will hold meetings as necessary but at least twice per year, at times and locations to be mutually agreed upon. The minutes of the meetings will be recorded and marked "confidential" and will be subject to the secrecy obligations and restrictions on use contained in Paragraphs 12.2 and 12.
(c) The Joint Research Committee will review and evaluate the work on the Research Collaboration. Its functions will be to decide:
(i) on Targets to be included within the Research Collaboration; * CONFIDENTIAL TREATMENT REQUESTED 6 (ii) on Research Target Profiles for any Target (including any subsequent modifications of such Research Target Profile);
Management of the Research Program. 5.1 Research Management Committee. -----------------------------
Management of the Research Program. The JMT shall establish and may amend the scientific objectives of the Research Program from time to time and shall review the progress
Management of the Research Program. 3.1 Steering Committee. Benitec and 4D Molecular hereby establish a Steering Committee to:
a. oversee the collaboration between the Parties;
b. review and evaluate the Research Program’s progress;
c. recommend to the Parties any amendments to revise or add studies to the Research Plan, for the Parties’ written approval and adoption if they are in agreement, according to Section 2.3;
d. coordinate the publication of the Research Program’s results;
e. monitor the exchange of information and materials between the Parties;
f. disclose to the other Party advances, new developments, and discoveries related to the Parties’ activities under this Agreement and the Research Plan; and
g. review and discuss AAV Capsid Variants proposed for selection and advancement to validation studies under the Research Program.
h. discuss and review the funding to the program, including management of records thereof.
i. discuss and approve budgets for the research program, as well as payments.
Management of the Research Program